Meng Du
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Circular RNAs in diseases 4
- RNA Interference and Gene Delivery 4
-
- Ultrasound and Hyperthermia Applications 11
- Nanoplatforms for cancer theranostics 8
- Photoacoustic and Ultrasonic Imaging 6
- Co-authors
- Zhiyi Chen (11 shared papers)Zhiyi Chen (6 shared papers)Yuhao Chen (4 shared papers)Minna Luo (5 shared papers)Shangke Huang (4 shared papers)Xinhan Zhao (3 shared papers)Shan Shao (3 shared papers)Lei Hou (3 shared papers)
- Journals
- Drug Delivery (3 papers)ACS Biomaterials Science & Engineering (2 papers)OncoTargets and Therapy (2 papers)Clinical & Translational Oncology (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Meng Du
49 papers receiving 915 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 172
- Biomaterials 124
- Biomedical Engineering 299
- Molecular Biology 371
- Oncology 142
Countries citing papers authored by Meng Du
This map shows the geographic impact of Meng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Du more than expected).
Fields of papers citing papers by Meng Du
This network shows the impact of papers produced by Meng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Du. The network helps show where Meng Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 127 | |
| 2 | 1998 | 79 | |
| 3 | 2018 | 71 | |
| 4 | 2020 | 63 | |
| 5 | 2018 | 41 | |
| 6 | 2020 | 38 | |
| 7 | 2018 | 34 | |
| 8 | 2020 | 34 | |
| 9 | 2013 | 31 | |
| 10 | 2018 | 29 | |
| 11 | 2018 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2019 | 26 | |
| 14 | 2014 | 26 | |
| 15 | 2009 | 25 | |
| 16 | 2019 | 23 | |
| 17 | 2020 | 20 | |
| 18 | 2020 | 20 | |
| 19 | 2018 | 19 | |
| 20 | 2021 | 17 |
About Meng Du
Meng Du is a scholar working on Molecular Biology, Biomedical Engineering, Cancer Research, Oncology and Biotechnology, having authored 52 papers that have together received 924 indexed citations. Recurring topics across this work include Ultrasound and Hyperthermia Applications (11 papers), Nanoplatforms for cancer theranostics (8 papers), Cancer Research and Treatments (6 papers), Photoacoustic and Ultrasonic Imaging (6 papers), Ultrasound Imaging and Elastography (4 papers), Circular RNAs in diseases (4 papers), RNA Interference and Gene Delivery (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (172 citations), Biomaterials (124 citations), Biomedical Engineering (299 citations), Molecular Biology (371 citations) and Oncology (142 citations). Meng Du has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhiyi Chen, Zhiyi Chen, Yuhao Chen, Minna Luo, Shangke Huang, Xinhan Zhao, Shan Shao, Lei Hou, Feng Lu and Yuhao Chen. Their work appears in journals such as Drug Delivery, ACS Biomaterials Science & Engineering, OncoTargets and Therapy, Clinical & Translational Oncology and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.